羚锐制药：董事陈燕拟减持不超过20万股

Core Viewpoint - The company, Lingrui Pharmaceutical, announced that its director, Chen Yan, plans to reduce his shareholding due to personal financial needs, which may impact investor sentiment and stock performance [1] Summary by Relevant Sections - Share Reduction Plan - Chen Yan intends to reduce his holdings by up to 200,000 shares, representing approximately 0.0353% of the company's total share capital [1] - The reduction will occur through centralized bidding transactions within three months after a 15 trading day period from the announcement date [1] - The selling price will be determined based on the market price at the time of the reduction [1]